Completed PHASE3 INTERVENTIONAL 2-arm NCT02268305

The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain

The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain.

Sponsor: Mike O'Callaghan Military Hospital

Interventions MSM 1000mg twice a day (6000 mgs) Placebo capsules twice a day

Updated 11 times since 2017 Last updated: Apr 3, 2024 Started: Feb 28, 2015 Primary completion: Jun 5, 2018 Completion: Jun 5, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02268305, this PHASE3 trial focuses on Low Back Pain and remains completed. Sponsored by Mike O'Callaghan Military Hospital, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
May 2024 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — May 2024 [monthly]

Completed PHASE3
Dec 2018 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 6 earlier versions

Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE3
Dec 2017 — Jun 2018 [monthly]

Recruiting PHASE3
Sep 2017 — Dec 2017 [monthly]

Recruiting PHASE3
Jun 2017 — Sep 2017 [monthly]

Recruiting PHASE3
Feb 2017 — Jun 2017 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mike O'Callaghan Military Hospital

Data source: Mike O'Callaghan Military Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nellis Air Force Base, United States